Healthcare Business Update: Sarepta Shares REBOUND, Glaxo Goes TRADITIONAL Chinese

Shares of Sarepta Therapeutics, Inc. (SRPT) dip but end in the green Friday, perhaps less affected now by news earlier this week that it had reached an at-the-market equity offering sales agreement with Citadel Securities. The stock has been on a big rally of late, gaining more than 300 percent just since mid-July when Sarepta released its 36-week data from the current phase IIb extension study of Eteplirsen, its potential treatment for Duchenne Muscular Dystrophy.

Don’t Miss: Apple is NOT Liable for These Never-Ending Costs.

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) posts significantly higher prescription growth in August for its top product, Acthar Gel. The firm reports that during the period, it shipped 2,190 vials of Acthar to CuraScript SD, which marks an increase of 33 percent month-over-month.

GlaxoSmithKline (NYSE:GSK) will inaugurate a research and evelopment facility in China, to study traditional Chinese medicine, at which it will try to develop modern drugs that are based on the traditional treatments. Senior Vice President Zang Jingwu, who is also chief of R&D China, says that “Traditional Chinese medicine is a well-established system of medical practice developed through thousands of years of empirical testing and refinement of herbal mixtures, and relies generally on clinical experience.”

Shares of Merge Healthcare Incorporated (NASDAQ:MRGE) lose much of Thursday’s gains, following word that its Board has hired Allen & Company to help it explore and evaluate a broad range of strategic alternatives, including a sale. In the meantime, Dougherty lowers the shares to Neutral, explaining that the firm’s fundamentals are weakening, making the determination of a value for the company all the more difficult, along with the possibility of any sale at all.

Don’t Miss: Here’s the Jobs Report Politicians Will Discuss for the Next Month.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>